| Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment S Lal, J La Du, RL Tanguay, JA Greenwood Journal of Neuroscience Research 90 (4), 769-781, 2012 | 73 | 2012 |
| Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2 HS Jang, S Lal, JA Greenwood Neurochemical research 35, 1796-1804, 2010 | 64 | 2010 |
| Phosphoinositide binding to the substrate regulates susceptibility to proteolysis by calpain CR Sprague, TS Fraley, HS Jang, S Lal, JA Greenwood Journal of biological chemistry 283 (14), 9217-9223, 2008 | 52 | 2008 |
| IGF1R as a key target in high risk, metastatic medulloblastoma MN Svalina, K Kikuchi, J Abraham, S Lal, MA Davare, TP Settelmeyer, ... Scientific reports 6 (1), 27012, 2016 | 31 | 2016 |
| Interactions between αv-integrin and HER2 and their role in the invasive phenotype of breast cancer cells in vitro and in rat brain S Lal, C Kersch, KA Beeson, YJ Wu, LL Muldoon, EA Neuwelt PLoS One 10 (7), e0131842, 2015 | 22 | 2015 |
| An oncolytic measles virus–sensitive Group 3 medulloblastoma model in immune-competent mice S Lal, D Carrera, JJ Phillips, WA Weiss, C Raffel Neuro-oncology 20 (12), 1606-1615, 2018 | 21 | 2018 |
| Using cystine knot proteins as a novel approach to retarget oncolytic measles virus S Lal, C Raffel Molecular Therapy-Oncolytics 7, 57-66, 2017 | 15 | 2017 |
| Safety study: Intraventricular injection of a modified oncolytic measles virus into measles-immune, hCD46-transgenic, IFNαRko mice RC Lal S, Peng KW, Steele MB, Jenks N, Ma H, Kohanbash G, Phillips JJ Human Gene Therapy Clinical Development, 2016 | 8 | 2016 |
| Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model S Ohshima-Hosoyama, MA Davare, SI Prajapati, J Abraham, S Lal, ... Journal of pediatric hematology/oncology 34 (2), 116-121, 2012 | 7 | 2012 |
| Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells MA Davare, S Lal, JL Peckham, SI Prajapati, SH Gultekin, BP Rubin, ... Biochemical and biophysical research communications 450 (1), 555-560, 2014 | 6 | 2014 |
| Psoriatic arthritis (A case report) S Lal, NC Gupta Indian journal of dermatology 18 (2), 29-30, 1973 | 1 | 1973 |
| Protocols to Manufacture an Oncolytic Measles Virus–Sensitive Immunocompetent Mouse Model of Medulloblastoma S Lal, C Raffel Medulloblastoma: Methods and Protocols, 165-177, 2022 | | 2022 |
| THER-16. INTERACTION OF IMMUNE SYSTEM WITH ONCOLYTIC MEASLES VIRUS THERAPY IN AN MV-SENSITIVE IMMUNOCOMPETENT MURINE MODEL OF MEDULLOBLASTOMA S Lal, S Mueller, N Gupta, C Raffel Neuro-Oncology 21 (Suppl 2), ii117, 2019 | | 2019 |
| Viral Targeting with Knottins C Raffel, S Lal US Patent App. 15/783,468, 2018 | | 2018 |
| AN ONCOLYTIC MEASLES VIRUS SENSITIVE GROUP 3 MEDULLOBLASTOMA MODEL IN IMMUNE-COMPETENT MICE S Lal, C Raffel NEURO-ONCOLOGY 19, 257-257, 2017 | | 2017 |
| Oncolytic Viral Therapy of Glioblastoma: Will this Soon become a Reality? SLJ Mukherjee Chemotherapy: Open Access 5 (4), DOI: 10.4172/2167-7700.1000e131, 2016 | | 2016 |
| Oncolytic Viral Therapy of Glioblastoma: Will this Soon become a Reality S Lal, J Mukherjee Chemo Open Access 5, e131, 2016 | | 2016 |
| Abstract A08: IGF1R as a key target in high risk, metastatic medulloblastoma MN Svalina, K Kikuchi, J Abraham, S Lal, MA Davare, JL Peckham, ... Cancer Research 75 (23_Supplement), A08-A08, 2015 | | 2015 |
| ATPS-70USING CYSTEINE KNOT PROTEINS TO RETARGET AN ONCOLYTIC VIRUS TO NOVEL CELL SURFACE ANTIGENS S Lal, C Raffel Neuro-oncology 17 (Suppl 5), v33, 2015 | | 2015 |
| NT-17TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) WITH AN ONCOLYTIC MEASLES VIRUS IN COMBINATION WITH INHIBITORS OF THE PI3-KINASE PATHWAY S Lal, S Lawrence, C Raffel Neuro-Oncology 16 (Suppl 5), v162, 2014 | | 2014 |
